Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 19,620
+196 (1.01%)
Nov 4, 2026, 3:29 PM IST
Neuland Laboratories Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 23,135 | 20,230 | 14,768 | 15,586 | 11,915 | 9,517 |
Revenue Growth | 50.87% | 36.98% | -5.24% | 30.81% | 25.20% | 1.57% |
Gross Profit Gross Profit Growth | 12,711 | 10,759 | 7,263 | 8,248 | 5,777 | 3,982 |
Operating Income Operating Income Growth | 6,122 | 4,880 | 2,650 | 4,033 | 2,306 | 960.9 |
Net Income Net Income Growth | 4,525 | 3,640 | 2,601 | 3,001 | 1,635 | 638.22 |
Earnings Per Share EPS Growth | 352.74 | 283.71 | 202.74 | 233.89 | 127.45 | 49.74 |
EPS Growth | 88.45% | 39.94% | -13.32% | 83.52% | 156.23% | -20.85% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 4,841 | 4,756 | 3,366 | 3,206 | 2,391 |
Europe Europe Growth | 6,754 | 4,291 | 4,630 | 3,601 | 2,682 |
Usa and North America Usa and North America Growth | 7,135 | 4,221 | 6,005 | 3,655 | - |
Rest of The World Rest of The World Growth | 1,500 | 1,500 | 1,585 | 1,450 | 1,627 |
Total Total Growth | 20,230 | 14,768 | 15,586 | 11,912 | 9,233 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 4,504 | 766.7 | 2,396 | 875.75 | 454.16 | 84.68 |
Total Debt Total Debt Growth | 3,423 | 3,013 | 1,571 | 953.9 | 1,284 | 2,405 |
Net Cash (Debt) Net Cash Growth | 1,081 | -2,246 | 824.76 | -78.14 | -830.34 | -2,321 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 84.28 | -175.06 | 64.28 | -6.09 | -64.72 | -180.88 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 7,450 | 3,467 | 3,174 | 2,612 | 2,372 | 603.89 |
Capital Expenditures CapEx Growth | -4,870 | -3,971 | -2,065 | -1,437 | -661.29 | -976.86 |
Free Cash Flow Free Cash Flow Growth | 2,580 | -504.52 | 1,109 | 1,175 | 1,711 | -372.97 |
Free Cash Flow Growth | - | - | -5.59% | -31.32% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 54.94% | 53.18% | 49.18% | 52.92% | 48.49% | 41.84% |
Operating Margin | 26.46% | 24.12% | 17.95% | 25.88% | 19.35% | 10.10% |
Pretax Margin | 26.31% | 24.17% | 23.45% | 25.76% | 18.11% | 8.63% |
Profit Margin | 19.56% | 17.99% | 17.61% | 19.25% | 13.72% | 6.71% |
FCF Margin | 11.15% | -2.49% | 7.51% | 7.54% | 14.36% | -3.92% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 34.000 | 34.000 | 12.000 | 14.000 | 10.000 | 5.000 |
Dividend Per Share Growth | 183.33% | 183.33% | -14.29% | 40.00% | 100.00% | 0% |
Dividend Yield | 0.17% | 0.28% | 0.10% | 0.22% | 0.56% | 0.49% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 55.62 | 42.34 | 59.57 | 26.86 | 14.12 | 20.64 |
P/FCF Ratio | 97.76 | - | 139.67 | 68.58 | 13.49 | - |
PS Ratio | 10.90 | 7.62 | 10.49 | 5.17 | 1.94 | 1.38 |